• Study of [18F]AlF-NOTA-Octreotide for Carotid Artery Disease in Patients with Recent Stroke or TIA

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study of Pembrolizumab and V940 for Treating Non-Small Cell Lung Cancer in Patients with Resectable Stage II to IIIB (N2) Not Achieving Complete Response

    Recruiting

    3 1 1
    Investigated diseases:
    Belgium Bulgaria Finland France Germany Greece +8
  • Comparison of Once Versus Twice Daily Prednisolone Administration on Blood Glucose Control in Patients with ANCA-Associated Vasculitis

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria
  • Study on Steroid Withdrawal in Systemic Lupus Erythematosus Patients Using Prednisone

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on the Safety and Benefits of Recombinant Human Plasma Gelsolin for Patients with Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS)

    Recruiting

    2 1
    Investigated diseases:
    Belgium Bulgaria Czechia France Germany Hungary +4
  • Study on Pressurized Intraperitoneal Aerosol Chemotherapy with Fluorouracil for Patients with Gastric Cancer with Peritoneal Metastases

    Recruiting

    3 1 1 1
    Investigated diseases:
    Italy
  • Study of nivolumab treatment for patients with nasopharyngeal cancer who did not respond to or worsened after platinum chemotherapy

    Recruiting

    2 1 1 1
    Investigated drugs:
    Poland
  • Study on the Safety and Effectiveness of MEDI0618 for Reducing Migraine Days in Adults with Episodic Migraine

    Recruiting

    2 1
    Investigated drugs:
    Czechia Denmark Germany Hungary Italy The Netherlands +2
  • Study on the Effectiveness of Dexamethasone in Preventing Prenatal Virilization in Female Patients with Congenital Adrenal Hyperplasia

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on Stopping Prednisone for Patients with Inflammatory or Autoimmune Disorders

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

powered by